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Liver injury in workers exposed to dimethylformamide
by Lora E Fleming, MD, MPH,' Stuart L Shalat, ScD,2 Carrie A Redlich, MD, MPH3
FLEMI NG LE, SHALAT SL, REDLICH CA. Liver injury in workers exposed to dimethylformam ide.
Scand J Work Environ Health 1990;16:289-92. An apparent epidemic cluster of toxic liver disease was
reexamined among workers exposed to the solvent dimethylformamide . A demographically similar but
unexposed group from a preemployment popula tion was used for comparison. Analysis, after data tran s-
formation of the liver transaminases, revealed significant differences between the two populations with
respect to the serum glutamic pyruvic transaminase and the ratio of serum glutamic oxaloacetic trans-
aminase to serum glutamic pyruvic transaminase. Thus a value of the ratio < 1 may be suggestive of toxic
liver disease. Medical surveillance of the working population for 14 months revealed no further cases of
toxic liver disease. Dimethylformamide was almost certainly the causative agent of the original epidemic.
The use of preemployment populations as a source of unexposed subjects in the analysis of occupat ional
clusters is recommended, especially in the scenario of relatively acute, and highly prevalent, occupational
diseases.
Key terms: cluster analysis , occupational clusters, preemployment screening.
The evaluation of an occupational disease often in-
volves cluster analysis or aggregate analysis or both
in that small groups of workers in a given industrial
location are reported to have an increased prevalence
of some disease which mayor may not be related to
their occupational exposures. However, these analyses
can be difficult. Small numbers, inadequate reference
populations , multiple exposure agents, and population
factors, not to mention the possibility of chance alone
leading to the apparent increase, are all problems
plaguing these analyses (1-6). Nevertheless, we feel
that various aspects of cluster and aggregate analyses,
previously applied to cancer and infectious disease
problems, are relevant to the investigation of occupa-
tional and environmental diseases.
In 1986, we discovered a cluster of toxic liver dis-
ease among workers exposed to the solvent dimethyl-
formamide (7). Thirty-five out of the 45 exposed pro-
duction workers had abnormalities of their liver trans-
aminases [serum glutamic oxaloacetic transaminase
(SOOT) (aspartate aminotransferase) and serum glu-
tamic pyruvic transaminase (SOPT) (alanine amino-
transferase)], while only one out of the 12 unexposed
nonproduction workers had such abnormalities. Spe-
cifically, the SOOT and/or SOPT levelwas significant-
ly elevated and the SOOT:SOPT ratio was < 1 for all
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but one of the exposed population. At the same time,
other indices of liver abnormality (such as bilirubin,
alkaline phosphatase, and viral serologies) were nor-
mal in the entire study population. Finally, liver
biopsies (including special fat stains and electron
microscopy) obtained from seven exposed individuals
showed evidence of microvesicular fat and hepatocel-
lular unrest, without significant inflammatory in-
filtrate. It was felt that the overall clinical and patho-
logical picture was consistent with an epidemic of liver
disease of a toxic origin (7, 8).
Concerns about this preliminary study included the
following: the small number of demographicallydiffer-
ent unexposed subjects, the inclusion of the three in-
dex cases, the possibility of some unidentified "popu-
lation" factor (such as increased prevalence of obesi-
ty, diabetes, alcohol abuse, non A non B viral hepati-
tis, previous occupational exposures, or merely a
different distribution of liver transaminases among the
population from which the exposed group of workers
came), the statistical distribution of the liver trans-
aminases, and the assertion that dimethylformamide
was the causative agent. We undertook the following
analysis in order to address these concerns and to es-
tablish that this cluster represented a real epidemic of
occupational liver disease.
Subjects and methods
Due to our role as the medical director of the com-
pany in which the epidemic of toxic liver disease took
place, over the past 14 months we were able to collect
a large case file of individuals undergoing preemploy-
ment medical screening. This screening involved,
among other things, a complete liver profile (ie, the
liver transaminases SOOT and SOPT, alkaline phos-
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phatase and bilirubin). Using this information, we were
able to assemble a population of men who were unex-
posed and demographically similar as the unexposed
population in our reanalysis. It should be noted that
preemployment data (induding height and weight) did
not exist for the exposed individuals.
To evaluate the actual cluster of exposed workers,
we elected to exclude from our analysis the three in-
dex cases since they could bias our results. We decided
to look only at the population of both the exposed and
the unexposed subjects who fulfilled the following
criteria: male, Hispanic (by last name), and only in ex-
posed jobs (ie, production, laminator, quality control).
This procedure created an exposed population of 41
individuals from the original 45, and an unexposed
population of 111 individuals from the preemployment
screening group of 136. We evaluated only the initial
liver transaminase values of all these individuals.
We reanalyzed the statistical distribution of the liver
transaminases and their ratio by performing a log
10 transformation. This transformation not only gave
a more normal distribution, but was also in accordance
with existing literature on the analysis of liver trans-
aminase values (9, 10). We then compared the exposed
and unexposed populations by performing t-tests , an
analysis of possible confounding variables, and, final-
ly, a multivariate regression analysis (including anal-
ysis of covariance) using the various relevant variables
available. These variables consisted of exposure sta-
tus, age, and liver transaminases with their ratio (ie,
SGOT:SGPT ratio); other variables such as race, sex,
and job category were the same between the exposed
and unexposed groups. All the statistical analyses were
performed with the use of the SAS (statistical analy-
sis system) program, version 6.02.
We were concerned about the possible confound-
ing effects of age. It was possible that the duration of
employment could be collinear with age. The original
investigation had shown that the liver transaminases
actually decreased with duration of employment (7).
In addition, there was evidence from the t-test that age
was significantly different between the two exposure
groups (P = 0.006). A regression analysis looking at age
alone in each exposure group separately revealed no
significant effect of age on any of the transformed liver
transaminases or their ratio. Therefore, age did not
appear to be an effect modifier .
Finally, several engineering and industrial hygiene
changes, with worker education in Spanish and Eng-
lish, were implemented in the workplace through the
efforts of the union and management. In add ition a
dramatic reduction occurred in the actual amount of
dimethylformamide used in production. Finally, medi-
cal surveillance in the form of a liver-profile blood
screen, carried out every three months, and a complete
annual medical evaluation had been implemented over
the past 14 months.
Results
First, we examined basic demographic information to
make comparisons between the exposed (N = 41) and
unexposed (N = 111)subjects. The exposed group was
slightly older on the average [mean 33.5 (median 29)
years] than the unexposed group [mean 28.2 (median
25) years] at the time of the initial screening. At-test
indicated that the age difference between the two
groups was statistically significant (P = 0.006).
We then examined the liver transaminases in each
of the two groups and found that the means and me-
dians of the liver transaminases and their ratio were
very different within each exposure group; that is, there
was evidence of a skewed distribution. We performed
log 10 tran sformations of the liver transaminase data,
and these transformations markedly normalized the
distributions in that they led to an increased corre-
spondence between the means and medians within each
exposure group. (See table 1 and figure 1.)
We then looked at t-test analyses that compared the
two groups after the log 10 transformations of the
data. In some contrast to the original investigation,
we found that the SGPT and the SGOT:SGPT ratio
were significantly different between the two groups
(P<O.OOOI for both), while the SGOT difference was
no longer statistically significant.
Since we were still concerned about a possible age
effect on the liver transaminase distributions and the
confounding effect of age in general, we elected to keep
age as a variable in the final analysis . We examined,
by multivariate regression analysis, models which in-
cluded the variables of exposure (a dichotomous vari-
able: exposed versus unexposed) and age (a continu-
ous variable) for each of the transformed liver trans-
aminases and their ratio. The analysis showed that
there were significant effects of exposure (with age)
on the liver transaminases and their ratio (with
P <0.0001 in the F-test for the SGPT and the ratio).
In other words, those workers who were in the exposed
Table 1. Untransformed and transformed (log 10) liver transaminase levels [serum glutamic oxaloacetic transaminase (SGOT)
and serum glutamic pyruvic transam inase (SGPT)] and their ratio (SGOT:SGPT).
Group
Exposed
Unexposed
SGOT (aspartate SGPT (alanine SGOT:SGPTaminotransferase) aminot ransferase)
N Untransformed Transformed Untransformed Transformed Untransformed Transformed
Mean Median Mean Median Mean Median Mean Median Mean Median Mean Median
41 64 35 1.62 1.54 94 49 1.77 1.69 0.73 0.71 -0.15 -0.15
111 42 30 1.52 1,48 46 28 1,49 1.45 1.16 1.07 0.025 0.029
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Figure 1. Distribution of the untrans-
formed and transformed (log 10) ratios
of serum glutamic oxaloacetic trans-
aminase (SGOTj to serum glutamic
pyruvic transaminase (SGPT) (exposed
and unexposed workers combined).
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Figure 2. Distribution of the trans-
formed (log 10) ratios (serum glutamic
oxaloacetic transaminase :serum glu -
tam ic pyruvic transaminase) of the ex-
posed and unexposed SUbjects sepa-
rately. (Non-exposed = unexposed)
group were more likely to have an increased SGPT
level and a SGOT:SGPT ratio of < I than the unex-
posed group . (See figure 2.) Again, the SGOT level
was not found to be statistically different between the
two groups. Of note, we did examine the possibility
of covariance between the two variables exposure and
age in our model and found it to be an appropriate
model with parallelism present and a normal distribu-
tion of the residuals.
Finally, the 14-month medical surveillance system,
with the engineering and industrial hygiene controls
already described, revealed no definite new cases of
liver disease in this workplace.
Discussion
We reexamined an apparent epidemic cluster of toxic
liver disease among workers exposed to the solvent
dimethylformamide. First we provided a new, larger,
and demographically similar unexposed group for
comparison. This population consisted of III Hispanic
men applying for exposed jobs. We also excluded the
original three index cases from the analysis. We thus
created two very similargroups in terms of demograph-
ic and , presumably, medical characteristics.
We then performed log 10 transformations of the
data in order to gain more normalized distributions
and thus a more statistically valid analysis of the data.
A multivariate regression analysis, after analysis for
possible confounding and covariance, revealed a sig-
nificant effect of exposure on the liver transaminase
status. Those who were exposed had significantly
elevated SGPT levels and were more likely to have an
SGOT:SGPT ratio of < 1.
From this analysis, we conclude the following. First,
the elevation of liver transaminases, in particular the
SGPT level, was not attributable to a population fac-
tor since we used as our comparison a demographi-
cally similar population. Since 20 % of the unexposed
population (as opposed to 59 % of the exposed) did
have one or more liver transaminase valuesgreater than
the laboratory normal for the liver transaminases, it
is possible that there was an increased rate of such fac-
tors as obesity, diabetes , non A non B viral hepatitis,
alcohol use, other occupational exposures, acquired
immunodeficiency disease, or intravenous drug use in
this general population. However, it should be noted
that there appeared to be a normal distribution of liver
transaminases within this population, with data trans-
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formation, which suggests that there may be some
slightly different population liver transaminase distri -
bution rather than an infectious or toxic etiology. In
terms of our own analysis, this possibility is irrelevant
since it did not prevent us from showing a statistically
different increase in the liver transaminases and their
ratio among the exposed workers when they were com-
pared with an unexposed population.
As with the preliminary investigation, we affirm that
an SGOT:SGPT ratio of < 1, especially when each of
the liver transaminases is <300 lUll, may be sugges-
tive of the diagnosis of toxic liver disease (7). This can
be a useful criterion for worker populations in which
the liver transaminases are often not so elevated as to
suggest acute viral hepatitis, but their increase does sug-
gest the possibility of alcoholic hepatitis. In addition,
an .elevated level of gamma glutamyl transpeptidase,
while extremely sensitive to any liver insult, does not
distinguish between alcoholic and toxic hepatitis (11,
12). However, past work has shown that with elevated
liver transaminases of < 300 and with SGOT:SGPT
ratios of > 2, there is a strong possibility of an alco-
holic etiology (13). Of note, 40 of our 41 exposed sub-
jects had a SGOT:SGPT ratio of < I, and all the sub -
jects' liver transaminases were below 300 lUll. None
of aur subjects were known diabetics, and, unfor-
tunately, height and weight were not available for the
exposed individuals.
As was mentioned, during the 14 months of medi-
cal surveillance, after significant reduction in and pro-
tection from the use of dimethylformamide, there have
been no new cases of toxic liver disease - despite the
new exposure of 138 new employees in this workplace
and the introduction of new solvents such as trichloro-
ethylene and methylene chloride. Thus we are almost
certain that dimethylformamide (or dimethylforma-
mide in synergism with some other agent or agents)
was the causative agent of the orig inal epidemic of
toxic liver disease. This possibility is further supported
by preexisting evidence in the literature of dimethyl-
formamide hepatotoxicity in both humans and animals
(14). Therefore, we recommend that this chemical, with
its extensive use and significant skin absorption, be
monitored closely in the future, especially since recent
investigations suggest that, in addition to its hepato-
toxic effects, dimethylformamide may also be a tes-
ticular carcinogen in humans (15, 16).
We recommend the use of preemployment screen-
ing as a useful source of unexposed comparison popu-
lations in the analysis of occupational clusters. We
believe that this technique would be especially useful
in clusters of fairly acute and highly prevalent diseases
(such as respiratory morbidity in the case of indoor
air pollution or acute toxic scenarios such as we have
described). In addition, it is also useful in workplaces
in which there is a relatively high turnover of employees
or a relatively large work force since it leads rapidly
to large numbers of preemployment individuals for
comparison groups in occupational cluster analysis.
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Finally, we hope that the work which has already
been done in infectious disease and cancer cluster anal-
ysis will be applied more extensively in the future to
occupational and environmental settings.
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